MindPeak's mission is to make microscopical analysis accessible for everyone in the world. We automate visual processes in the clinical laboratory with Artificial Intelligence and Deep Learning.
Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building.
Mindpeak's Impact
The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge.
We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building.
Mindpeak's Impact
The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge.
We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
Location: Germany, Hamburg
Employees: 11-50
Total raised: $18.3M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Motu Ventu... | motu.vc |
| - | Innovation... | innovation... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.09.2024 | Series A | $15.3M | - |
| 30.09.2019 | - | $3M | - |
Mentions in press and media 18
| Date | Title | Description |
| 14.09.2026 | Beyond the Algorithm: What Does It Take to Make AI Work in Everyday Pathology? | Mindpeak highlights the practical requirements for integrating AI into digital pathology workflows at ECP 2026 HAMBURG, GERMANY, September 14, 2026 /EINPresswire.com/ -- Artificial intelligence is becoming increasingly established in digita... |
| 11.09.2026 | Mindpeak Earns IVDR Certification, Reinforcing Its Commitment to Quality and Regulatory Excellence | Mindpeak Recieves IVDR Certificate HAMBURG, GERMANY, September 11, 2026 /EINPresswire.com/ -- Certification under the EU's In Vitro Diagnostic Regulation validates Mindpeak's quality management system, confirming it meets the EU's most rigo... |
| 24.03.2026 | Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials | New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development HUNTSVILLE, Ala. and HAMBURG, Germany, March 24, 2026 /PRNewswire/ -- Inconsistent biomarker interpretation acro... |
| 19.03.2026 | Mindpeak Announces Global Reseller Agreement with Leica Biosystems to Expand Access to AI Pathology Solutions | Accelerating biomarker discovery, standardising diagnostics and enabling smarter decisions across the drug development pipeline. Mindpeak today announced a global reseller agreement with Leica Biosystems, a Danaher company and a global lead... |
| 17.09.2025 | Mindpeak Strengthens Board with Appointment of Christiaan Neeleman to Accelerate Global Expansion in AI Pathology | Christiaan Neeleman joins Mindpeak's Board Directors Christiaan Neeleman joins Mindpeak’s Board of Directors to accelerate the company’s global growth and partnerships across pharma, biotech, and diagnostics. I am truly excited to actively ... |
| 10.07.2025 | Mindpeak Joins Techcyte Fusion Partner Program to Accelerate AI-Powered Digital Pathology | Mindpeak joins Techcyte Fusion Partner Program We believe the future of pathology depends on the widespread adoption of workflow-based, AI-enabled digital pathology.” — Matt Smith, Chief Strategy Officer, TechcyteOREM, UT, UNITED STATES, Ju... |
| 19.03.2025 | Mindpeak to Deploy AI-Powered Digital Pathology Risk Assessment Tool for Breast Cancer in Collaboration with AstraZeneca | AstraZeneca and Mindpeak Announce Partnership Partnership to evaluate Mindpeak Breast H&E AI software for primary breast cancer diagnosis in Brazil, Egypt, and Kenya The collaboration with Mindpeak underscores our commitment to transfor... |
| 03.10.2024 | The Rise of Water Tech: Pluvion's €1 Million Boost and the Future of Water Management | In an era where water scarcity looms large, innovative solutions are more crucial than ever. Enter Pluvion, a Freiburg-based startup that has recently secured €1 million in pre-seed funding. This investment is not just a financial boost; it... |
| 02.10.2024 | Mindpeak sammelt 15,3 Millionen ein – bcause erhält 4,2 Millionen – fynk bekommt 3,1 Millionen | Im #DealMonitor für den 2. Oktober werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-A... |
| 01.10.2024 | Mindpeak Secures $15.3 Million to Transform Cancer Diagnostics | In the realm of healthcare, innovation is the lifeblood that drives progress. Mindpeak, a Hamburg-based company, has just injected a fresh dose of capital into its mission to revolutionize cancer diagnostics. The company recently announced ... |
Show more